To promote and understand the structure—property relationship for hemostasis, we modified melittin (MLT) using a four-arm poly(ethylene glycol) (PEG) with N-hydroxysuccinimide ester. The PEGylation was characterized by FTIR, MALDI-MS, NMR, a bicinchoninic acid assay, circular dichroism, hemolysis assay, and thromboelastography. Changes in the reaction conditions affected the extent of the modification, the numbers of MLT conjugated to PEG arms, and possible PEGylation sites. The reaction at pH 9.2 with a high MLT/PEG ratio, resulted in the highest modification. Reactions in dimethylsulfoxide (DMSO) resulted in more multi-arm coupled MLT, reaching a maximum of four MLT per PEG. The helicity of the modified peptide, relative to the native peptide, was essentially maintained in DMSO, but substantially lost at pH 9.2. PEGylation reduced the hemolytic effects of MLT and subsequently changed its coagulation profiles. The overall hemostatic effects of MLT modified in DMSO indicate that this may be a convenient approach to the PEGylation of biomolecules for biomedical applications.
Gauldie, J., Hanson, J.M., Rumjanek, F.D., Shipolini, R.A. and Vernon, C.A. ( 1976). The Peptide Components of Bee Venom, Eur. J. Biochem., 61: 369-376.
2.
Terwilliger, T.C. and Eisenberg , D. (1982). The Structure of Melittin II. Interpretation of the Structure, J. Biol. Chem., 257: 6016-6022.
3.
Bazzo, R., Tappin, M.J., Pastore, A., Harvey, T.S., Carver, J.A. and Campbell, I.D. ( 1998). The Structure of Melittin A 1H-NMR Study in Methanol, Eur. J. Biochem., 173: 139-146.
4.
Weaver, A.J. , Kemple, M.D. and Prendergast , F.G. (1989 ). Characterization of Selectively 13C-labeled Synthetic Melittin and Melittin Analogues in Isotropic Solvents by Circular Dichroism, Fluorescence, and NMR Spectroscopy, Biochemistry, 28: 8614-8623.
5.
Bello, J., Bello, H.R. and Grandados, E. ( 1982). Conformation and Aggregation of Melittin: Dependence on pH and Concentration, Biochemistry, 2: 461-465.
6.
Terra, R.M.S. , Guimarães , J.A. and Verli, H. (2007). Structural and Functional Behavior of Biologically Active Monomeric Melittin , J. Mol. Graph. Model, 25: 767-772.
7.
Asthana, N., Yadav, S.P. and Ghosh, J.K. ( 2004). Dissection of Antibacterial and Toxic Activity of Melittin , J. Biol. Chem., 279: 55042-55050.
8.
Park, H.J., Son, D.J., Lee, C.W., Choi, M.S., Lee, U.S., Song, H.S. et al. (2007). Melittin Inhibits Inflammatory Target Gene Expression and Mediator Generation via Interaction with Iκb Kinase, Biochem . Pharmacol., 73: 237-247.
9.
Boeckle, S. , Fahrmeir, J., Roedl, W., Ogris, M. and Wagner, E. ( 2006). Melittin Analogs with High Lytic Activity at Endosomal pH Enhance Transfection with Purified Targeted PEI Polyplexes, J. Control. Rel., 112: 240-248.
10.
Cui, F. , Cun, D., Tao, A., Yang, M., Shi, K., Zhao, M. et al. (2005). Preparation and Characterization of Melittin-loaded Poly(DL-lactic acid) or Poly(DL-lactic-co-glycolic acid) Microspheres Made by the Double Emulsion Method, J. Control. Rel., 107: 310-319.
11.
Holle, L., Song, W., Holle, E., Wei, Y.-Z., Wagner, T. and Yu, X.-Z. ( 2003). A Matrix Metalloproteinase 2 Cleavable Melittin/Advidin Conjugate Specifically Targets Tumor Cells In Vitro and In Vivo, Int. J. Oncol., 22: 93-98.
12.
Yalcin, M., Ak, F. and Erturk, M. ( 2006). The Role of the Central Thromboxane A2 in Cardiovascular Effects of a Phospholipase A2 Activator Melittin Administrated Intracerebroventricularly in Normotensive Conscious Rats, Neuropeptides, 40: 207-212.
13.
Morgan, N.G. , Rumford, G.M. and Montague, W. (1985). Studies on the Mechanism by which Melittin Stimulates Insulin Secretion from Isolated Rate Islets of Langerhans, Biochim. Biophys. Acta , 845: 525-532.
14.
Zhao, Z., Rolli, H. and Schneider, C.H. ( 1995). Immunogenicity of Dinitrocarboxyphenylated Melittin: The Influence of C-Terminal Chain Shortening, N-Terminal Substitution and Prolin Insertion at Positions 5 and 10, J. Pept. Sci., 1: 140-148.
15.
Hider, R.C. , Khader, F. and Tatham, A.S. (1983). Lytic Activity of Monomeric and Oligomeric Melittin, Biochim. Biophys. Acta, 728: 206-214.
16.
Ramalingam, K., Aimoto, S. and Bello, J. (1992). Conformational Studies of Anionic Melittin Analogues: Effect of Peptide Concentration, pH, Ionic Strength, and Temperature-Models for Protein Folding and Halophilic Proteins, Biopolymers, 32: 981-992.
17.
Lavignac, N. , Lazenby, M., Franchini , J., Ferruti, P. and Duncan, R. (2005). Synthesis and Preliminary Evaluation of Poly(Amidoamine)-Melittin Conjugates as Endosomolytic Polymers and/or Potential Anticancer Therapeutics, Int. J. Pharm., 300: 102-112.
18.
Legendre, J.Y. , Trzeciak, A., Bohrmann , B., Deuschle, U., Kitas, E. and Supersaxo, A. (1997). Dioleoylmelittin as a Novel Serum-Insensitive Reagent for Efficient Transfection of Mammalian Cells, Bioconjug. Chem., 8: 57-63.
19.
Asthana, N. , Yadav, S.P. and Ghosh, J.K. (2004). Dissection of Antibacterial and Toxic Activity of Melittin, J. Biol. Chem., 279: 55042-55050.
20.
Sun, X. , Chen, S., Li, S., Yan, H., Fan, Y. and Mi, H. ( 2005). Deletion of Two C-Terminal Gln Residues of 12-26-Residue Fragment of Melittin Improves its Antimicrobial Activity, Peptides, 26: 369-375.
21.
Ahmad, A., Yadav, S.P., Asthana, N., Mitra, K., Srivastava, S.P. and Ghosh, J.K. ( 2006). Utilization of an Amphipathic Leucine Zipper Sequence to Design Antibacterial Peptides with Simultaneous Modulation of Toxic Activity against Human Red Blood Cells, J. Biol. Chem., 281: 22029-22038.
22.
Harris, J.M. and Chess, R.B. ( 2003). Effect of Pegylation on Pharmaceuticals, Nat. Rev. Drug Discov., 2: 214-221.
23.
Veronese, F.M. and Pasut, G. (2005). PEGylation, Successful Approach to Drug Delivery, Drug Discov. Today, 10: 1451-1458.
24.
Vandermeulen, G.W.M., Hinderberger , D., Xu , H., Sheiko, S.S., Jeschke, G. and Klok, H.-A. (2004). Structure and Dynamics of Self-Assembled Poly(Ethylene Glycol) Based Coiled-Coil Nano-Objects, ChemPhysChem., 5: 488-494.
25.
Lih, E. , Joung, Y.K., Bae , J.W. and Park, K.D. (2008). An In Situ Gel-Forming Heparin-Conjugated PLGA-PEG-PLGA Copolymer, J. Bioact. Compat. Polym., 23: 444-457.
26.
Sanborn, T.J. , Messersmith, P.B. and Barron, A.E. (2002). In Situ Crosslinking of a Biomimetic Peptide-PEG Hydrogel via Thermally Triggered Activation of Factor XIII, Biomaterials, 23: 2703-2710.
27.
Fichter, K.M. , Zhang, L., Kiick , K.L. and Reineke, T.M. (2008). Peptide-Functionalized Poly(Ethylene Glycol) Star Polymers: DNA Delivery Vehicles with Multivalent Molecular Architecture, Bioconjug. Chem. , 19: 76-88.
28.
Schmieder, A.H., Grabski, L.E., Moore, N.M., Dempsey, L.A. and Sakiyama-Elbert , S.E. ( 2007). Development of Novel Poly(Ethylene Glycol)-based Vehicles for Gene Delivery, Biotechnol. Bioeng., 96: 967-976.
29.
Schiavon, O. , Pasut, G., Moro , S., Orsolini, P., Guiotto, A. and Veronese, F.M. (2004). PEG-Ara-C Conjugates for Controlled Release, Eur. J. Med. Chem., 39: 123-133.
30.
Mero, A., Schivavon, O., Pasut, G., Veronese, F.M., Emilitri, E. and Ferruti, P. ( 2009). A Biodegradable Polymeric Carrier Based on PEG for Drug Delivery, J. Bioact. Compat. Polym., 24: 220-234.
31.
Blostein, M.D. , Rigby, A.C., Furie, B., Furie, B.C. and Gilbert, G.G. (2000). Amphipathic Helices Support Function of Blood Coagulation Factor IXa, Biochemistry , 39: 12000-12006.
Triantaphyllopoulos, E. (1970). Hemolysis and Blood Coagulation: Evidence of Inhibitory Effects, Life Sci., 7, part II: 99-110.
34.
Woolfson, D.N. and Ryadnov, M.G. (2006). Peptide-Based Fibrous Biomaterials: Some Things Old, New and Borrowed, Curr. Opin. Chem. Biol., 10: 559-567.
35.
Klok, H.-A. ( 2005). Biological-Synthetic Hybrid Block Copolymers: Combining the Best from Two Worlds, J. Polym. Sci., 43: 1-17.
36.
Ellis-Behnke, R.G., Liang, Y.-X., Tay , D.K.C., Kau , P.W.F., Schneider, G.E., Zhang, S. et al. (2006). Nano Hemostat Solution: Immediate Hemostasis at the Nanoscale, Nanomed: Nanotech . Biol. Med., 2: 207-215.
37.
Chowdhury, S.P. , Doleman, M. and Johnston, D. (1995). Fingerprinting Proteins Coupled with Polymers by Mass Spectrometry: Investigation of Polyethylene Glycol-Conjugate Superoxide Dismutase, J. Am. Soc. Mass Spectrom. , 6: 478-487.
38.
Na, D.H. , Youn, Y.S. and Lee, K.C. ( 2003). Optimization of the Pegylation Process of a Peptide by Monitoring with Matrix-assisted Laser Desorption/ Ionization Time-Of-Flight Mass Spectrometry, Rapid Commun. Mass Spectrom., 17: 2241-2244.
39.
Lauterwein, J. , Brown, L.R. and Wüthrich , K. (1980 ). High-Resolution 1H-NMR Studies of Monomeric Melittin in Aqueous Solution, Biochim. Biophys. Acta, 622: 219-230.
40.
Digilio, G. , Barbero, L., Bracco , C., Corpillo, D., Esposito, P., Piquet, G. et al. (2003 ). NMR Structure of Two Novel Polyethylene Glycol Conjugates of the Human Growth Hormone-Releasing Factor, Hgrf(1-29)-NH2, J. Am. Chem. Soc., 125: 3458-3470.
41.
Belcheva, N. , Baldwin, S.P. and Saltzman, W.M. (1998). Synthesis and Characterization of Polymer-(Multi)-Peptide Conjugates for Control of Specific Cell Aggregation , J. Biomater. Sci. Polym. End. , 9: 207-226.
42.
Zhang, L., Furst, E.M. and Kiick, K.L. ( 2006). Manipulation of Hydrogel Assembly and Growth Factor Delivery via the Use of Peptide-Polysaccharide Interactions, J. Control. Rel., 114: 130-142.
43.
Okada, A., Wakamatsu, K., Miyazawa, T. and Higashijima, T. ( 1994). Vesicle-Bound Conformation of Melittin: Transferred Nuclear Overhauser Enhancement Analysis in the Presence of Perdeuterated Phosphatidylcholine Vesicles, Biochemistry, 33: 9438-9446.
44.
Vig, S. , Chitolie, A., Bevan , D., Haliday, A. and Dormandy, J. (2001). Thromboelastography: A Reliable Test? Blood Coagul. Fibrinolysis , 12: 555-561.
45.
Zhao, H., Rubio, B., Sapra, P., Wu, D., Reddy, P., Sai, P. et al. (2008). Novel Prodrugs of SN38 Using Multiarm Poly(Ethylene Glycol) Linkers, Bioconjug. Chem., 19: 849-859.
46.
Yu, H., Feng, Z.-G., Zhang, A.-Y., Sun, L.-G. and Qian, L. ( 2006). Synthesis and Characterization of Three-Dimensional Crosslinked Networks Based on Self-Assembly of α-Cyclodextrins with Thiolated 4-Arm PEG Using a Three-Step Oxidation, Soft Matter, 2: 343-349.
47.
Wallace, D.G. , Cruise, G.M., Rhee, W.M., Schroeder, J.A., Prior, J.J., Ju , J. et al. (2001). A Tissue Sealant Based on Reactive Multifunctional Polyethylene Glycol, J. Biomed. Mater. Res., 58: 545-555.
48.
Seal, B.L. and Panitch, A. ( 2006). Physical Matrices Stabilized by Enzymatically Sensitive Covalent Crosslinks, Acta Biomater., 2: 241-251.
49.
Xu, H., Kaar, J.L., Russell, A.J. and Wagner, W.R. ( 2006). Characterizing the Modification of Surface Proteins with Poly(Ethylene Glycol) to Interrupt Platelet Adhesion, Biomaterials , 27: 3125-3135.
50.
Na, D.H. , Youn, Y.S. and Lee, K.C. ( 2003). Optimization of the Pegylation Process of a Peptide by Monitoring with Matrix-Assisted Laser Desorption/ Ionization Time-Of-Flight Mass Spectrometry, Rapid Commun. Mass Spectrom., 17: 2241-2244.
51.
Larson, R.S. , Menard, V., Jacobs, H. and Kim, S.W. ( 2001). Physicochemical Characterization of Poly(Ethylene Glycol)-Modified Anti-GAD Antibodies, Bioconjug. Chem., 12: 861-869.
52.
Barker, T.H. , Fuller, G.M., Klinger, M.M., Feldman, D.S. and Hagood, J.S. ( 2001). Modification of Fibrinogen with Poly(Ethylene Glycol) and its Effects on Fibrin Clot Characteristics , J. Biomed. Mater. Res., 56: 529- 535.
53.
Ramalingam, K., Bello, J. and Aimoto, S. (1993). Permethylation Alters the Conformational Transitions and the Complexing Ability of Melittin: A Model for Methylated Proteins, Biopolymers , 33: 305-314.
54.
Sumbatyan, N.V., Mandrugin, V.A., Deroussent, A., Bertrand, J.R., Majer, Z., Malvy, C. et al. (2004). The Solution Synthesis of Antisense Oligonucleotide-Peptide Conjugates Directly Linked via Phosphoramide Bond by Using a Fragment Coupling Approach, Nucleos . Nucleot. Nucleic Acids, 23: 1911-1927.
55.
Kinstler, O.B. , Brems, D.N., Lauren, S.L., Paige, A.G., Hamburger, J.B. and Treuheit, M.J. ( 1996). Characterization and Stability of N-terminally PEGylated rhG-CSF, Pharm. Res., 13: 996-1002.
56.
Maulet, Y., Mathey-Prevot, B., Kaiser, G., Rüegg, U.T. and Fulpius, B.W. ( 1980). Purification and Chemical Characterization of Melittin and Acetylated Derivatives, Biochim. Biophys. Acta , 625: 274-280.
57.
Morpurgo, M. and Veronese, F.M. (2004). Conjugates of Peptide and Proteins to Polyethylene Glycol, MethodsMol. Biol., 283: 45-70.
58.
Goto, Y. and Hagihara, Y. ( 1992). Mechanism of the Conformational Transition of Melittin , Biochemistry, 31: 732-738.
59.
Kemple, M.D. , Buckley, P., Yuan , P. and Prendergast , F.G. (1997 ). Main Chain and Side Chain Dynamics of Peptides in Liquid Solution from 13C NMR: Melittin as a Model Peptide, Biochemistry , 36: 1678-1688.
60.
Stigsnaes, P., Frokjaer, S., Bjerregaard , S., van de Weert, M., Kingshott, P. and Moeller, E.H. (2007). Characterisation and Physical Stability of PEGylated Glucagon, Int. J. Pharm., 330: 89-98.
61.
Ius, A. , Bacigalupo, M.A., Longhi, R. and Meroni, G. (2000). Selectively Conjugated Melittins for Liposome Time-Resolved Fluoroinnumoassay of Theophylline in Serum, FreseniusJ. Anal. Chem., 366: 869-872.
62.
Werkmeister, J.A., Hewish, D.R., Kirkpatrick, A. and Rivett, D.E. ( 2002). Sequence Requirements for the Activity of Membrane-active Peptides, J. Pept Res. , 60: 232-238.
63.
Blondelle, S.E. and Houghten , R.A. (1991). Hemolytic and Antimicrobial Activities of the Twenty-Four Individual Omission Analogues of Melittin, Biochemistry, 30: 4671-4678.
64.
Lin, S.C. , Huang, T.F. and Ouyang, C. (1983). Characterization of the Purified Anticoagulant Principles from Apis Mellifera (Honey Bee) Venom, J. Formos. Med. Assoc., 82: 629-639.
